Effect of ionic products of dicalcium silicate coating on osteoblast differentiation and collagen production via TGF-β1 pathway

Journal of Biomaterials Applications

Volumn 27, Issue 5, 2013, Pages 595-604

  Li, Jianyou ^a   Wei, Li ^b   Sun, Junying ^b   Guan, Guohua ^a  

^a HUZHOU CENTRAL HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

cell differentiation; Dicalcium silicate; gene expression; osteoblast; PGE2; TGF 1

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; CA2SIO4; CELL DIFFERENTIATION; CELLULAR DIFFERENTIATION; CONTROL GROUPS; CULTURE MEDIUM; DICALCIUM SILICATE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL GROUPS; GROWTH FACTOR; IN-CONTROL; IONIC PRODUCTS; MG63 CELLS; OSTEOBLAST DIFFERENTIATION; OSTEOBLASTIC ACTIVITY; OSTEOCALCIN; PGE2; PLASMA SPRAYED; PROSTAGLANDIN E2; REAL-TIME PCR; TRANSFORMING GROWTH FACTORS;

CELLS; COATINGS; COLLAGEN; GENE EXPRESSION; OSTEOBLASTS; PHOSPHATASES; PLASMA SPRAYING; POLYMERASE CHAIN REACTION; SILICATES;

CELL CULTURE;

ALKALINE PHOSPHATASE; CALCIUM DERIVATIVE; COLLAGEN; DICALCIUM SILICATE; ION; PRIMER DNA; PROSTAGLANDIN E2; SILICATE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIUM; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION;

ALKALINE PHOSPHATASE; BASE SEQUENCE; CALCIUM COMPOUNDS; CELL DIFFERENTIATION; CELL LINE; COLLAGEN; CULTURE MEDIA; DINOPROSTONE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMANS; IONS; OSTEOBLASTS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SILICATES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84871597633     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328211416393     Document Type: Article

References (49)

1. Jones JR, Hench LL. Effect of surfactant concentration and composition on the structure and properties of sol-gel-derived bioactive glass foam scaffolds for tissue engineering. J Mater Sci. 2003 ; 38 (18). 3783-3790
2. Jones JR, Tsigkou O, Coates EE, Stevens MM, Polak JM, Hench LL. Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. Biomaterials. 2007 ; 28 (9). 1653-1663
3. Lossdörfer S, Schwartz Z, Lohmann CH, Greenspan DC, Ranly DM, Boyan BD. Osteoblast response to bioactive glasses in vitro correlates with inorganic phosphate content. Biomaterials. 2004 ; 25 (13). 2547-2555
4. Liu XY, Tao SY, Ding CX. Bioactivity of plasma sprayed dicalcium silicate coatings. Biomaterials. 2002 ; 23 (3). 963-968
5. Xie YT, Liu XY, Ding CX, Paul K Chu. Bioconductivity and mechanical properties of plasma-sprayed dicalcium silicate/zirconia composite coating. Mater Sci Eng C. 2005 ; 25 (4). 509-515
6. Liu X, Morra M, Carpi A, Li B. Bioactive calcium silicate ceramics and coatings. Biomed Pharmacother. 2008 ; 62 (8). 526-529
7. Lamy D, Pierrc AC, Heimann RB. Hydroxyapatite coatings with a bond coat of biomedical implants by plasma projection. J Mater Res. 1996 ; 11 (3). 680-686
8. Xie YT, Liu XY, Paul K, Chu Zheng XB, Ding CX. Bioactive titanium-particle-containing dicalcium silicate coating. Surf Coat Technol. 2005 ; 200 (5-6). 1950-1953
9. Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metabol Disorders. 2001 ; 2 (1). 81-94
10. Boneward LF, Transforming Growth Factor-β Principles of bone biology. 2 nd ed. San Diego: Academic Press, 2002, p.903-918. Bilezikian JP Raisz LG Rodan GA, ed. San Diego: Academic Press ; 2002: 903-918.
11. Kassem M, Kveiborg M, Eriksen EF. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Eur J Clin Invest. 2000 ; 30 (5). 429-437
12. Raisz LG, Fall PM. Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocr. 1990 ; 126 (3). 1654-1659
13. Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubo F, et al. The role of prostaglandin E receptor subtypes (EP1. EP2, Ep3, and EP4) in bone resorption: an analysis using specific agonist for the respective EPs. Endocrinology. 2000 ; 141 (4). 1554-1559
14. Gruber R, Nothegger G, Ho GM, Willheim M, Peterlik M. Differential stimulation by PGE2 and calcemic hormones of IL-6 in stromal/osteoblastic cells. Biochem Biophys Res Commun. 2000 ; 270 (3). 1080-1085
15. Weinreb M, Machwate M, Shir N, Abramovitz M, Rodan GA, Harada S. Expression of the prostaglandin E2 (PGE2) receptor subtype EP(4) and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue. Bone. 2001 ; 28 (3). 275-281
16. Kaneki H, Takasugi I, Fujieda M, Kiriu M, Mizuochi S, Ide H. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J Cell Biochem. 1999 ; 73 (1). 36-48
17. Opas EE, Gentile MA, Rossert JA, de Crombrugghe B, Rodan GA, Schmidt A. Parathyroid hormone and prostaglandin E2 preferentially increase luciferase levels in bone of mice harboring a luciferase transgene controlled by elements of the pro-alpha1(I) collagen promoter. Bone. 2000 ; 26 (1). 27-32
18. Li M, Healy DR, Li Y, Simmons HA, Crawford DT, Ke HZ, et al. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone. 2005 ; 37 (1). 46-54
19. Jee WS, Ma YF. The in vivo anabolic actions of prostaglandins in bone. Bone. 1997 ; 21 (4). 297-304
20. Ramirez-Yañez GO, Hamlet S, Jonarta A, Seymour GJ, Symons AL. Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study, Prostaglandins. Leukot Essen Fatty Acids. 2006 ; 74 (3). 183-192
21. Jorgensen NR, Henriksen Z, Sorensen OH, Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids. 2004 ; 69 (4). 219-226
22. Woodiel FN, Fall PM, Raisz LG. Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway. J Bone Miner Res. 1996 ; 11 (9). 1249-1255
23. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Rel Res. 1995 ; 313: 36-46
24. Bigi A, Bracci B, Cuisinier F, Elkaim R, Fini M, Mayer I, et al. Human osteoblast response to pulsed laser deposited calcium phosphate coating. Biomaterials. 2005 ; 26 (15). 2381-2389
25. Borsari V, Giavaresi G, Fini M, Torricelli P, Tschon M, Chiesa R, et al. Comparative in vitro study on a ultra-high roughness and dense titanium coating. Biomaterials. 2005 ; 26 (24). 4948-4955
26. Lohmann CH, Sagun R, Sylvia VL, Cochran DL, Dean DD, Boyan BD, et al. Surface roughness modulates the response of MG63 osteoblast-like cells to 1,25-(OH)2D3 through regulation of phospholipase A(2) activity and activation of protein kinase A. J Biomed Mater Res. 1999 ; 47 (2). 139-151
27. Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, Glant TT. The effects of particulate wear debris, cytokines and growth factors on the functions of MG63 osteoblasts. J Bone Joint Surg Am. 2001 ; 83 A (2). 201-211
28. Sun JY, Wei L, Liu XY, Li JY, Li BE, Wang GC, et al. Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression. Acta Biomaterialia. 2009 ; 5 (4). 1284-1293
29. Tullberg-Reinert H, Jundt G. In situ measurement of collagen synthesis by human bone cells with Sirius-Red based colorimetric microassay. Histochem Cell Biol. 1999 ; 112 (4). 271-276
30. Boskey AL, Wright TM, Blank RD. Collagen and bone strength. J Bone Miner Res. 1999 ; 14: 330-335
31. Patricia V, Marivalda MP, Alfredo MG, Fatima L. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials. 2004 ; 25 (15). 2941-2948
32. Seaborn CD, Nielsen FH. Silicon deprivation decreases collagen formation in wounds and bone, and ornithine transaminase enzyme activity in liver. Biol Trace Elem Res. 2002 ; 89 (3). 251-261
33. Bosetti M, Zanardi L, Hench LL, Cannas M. Type I collagen production by osteoblast like cells cultured in contact with different bioactive glasses. J Biomater Res. 2003 ; 64 A (1). 189-195
34. Birchall JD. The essentiality of silicon in biology. Chem Soc Rev. 1995 ; 24 (5). 351-357
35. Xynos ID, Alasdair JE, Buttery LDK. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophy Res Commun. 2000 ; 276 (2). 461-465
36. Sun HL, Wu CT, Dai KR, Chang J, Tang TT. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal dells on akermanite-bioactive ceramics. Biomaterials. 2006 ; 27 (33). 5651-5657
37. Tang Q, Brooks R, Rushton N, Best S. Production and characterization of HA and SiHA coatings. J Mater Sci: Mater Med. 2010 ; 21 (1). 173-181
38. Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HFJ, Evans BAJ, Hampson GN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003 ; 32 (2). 127-135
39. Heberden C, Denis I, Pointillart A, Mercier T. TGF-β and calcitriol. Gen Pharmacol. 1998 ; 30 (2). 145-151
40. Keeting PE, Oursler MJ, Weigand KE, Bonde SK, Spelsberg TC, Riggs BL. Zeolite A increases proliferation, differentiation, and transforming growth factor beta production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res. 1992 ; 7 (11). 1281-1289
41. Lilli C, Marinucci L, Stabellini G, Belcastro S, Becchetti E, Balducci C, et al. Biomembranes enriched with TGFβ1 favor bone matrix protein expression by human osteoblasts in vitro. J Biomed Mater Res. 2002 ; 63 (5). 577-582
42. Centrella M, McCarthy TL, Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem. 1987 ; 262 (6). 2869-2874
43. Hyytiainen M, Penttinen C, Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci. 2004 ; 41 (3). 233-264
44. Chang W, Parra M, Ji C, Liu Y, Eickelberg O, McCarthy TL, et al. Transcriptional and post-transcriptional regulation of transforming growth factor β type II receptor expression on osteoblasts. Gene. 2002 ; 299 (1-5). 65-77
45. Centrella M, Ji C, Casinghino S, McCarthy TL. Rapid flux in transforming growth factor-β receptors on bone cells. J Biol Chem. 1996 ; 271 (31). 18616-18622
46. Pikington MF, Sims SM, Dixon SJ. Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment. J Bone Miner Res. 2001 ; 16 (7). 1237-1247
47. Janssens K, Dijke P, Janssens S, Van Hul W. Transforming growth factor-β1 to the bone. Endocr Rev. 2005 ; 26: 743-774
48. Heldin CH, Miyazono K, ten Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature. 1997 ; 390 (6659). 465-471
49. Conconi MT, Tommasini M, Baiguera S, De Coppi P, Parnigotto PP, Nussdorfer GG. Effects of prostaglandins E1 and E2 on the growth and differentiations of osteobalst-like cells cultured in vitro. Int J Mol Med. 2002 ; 10 (4). 451-456